Clinical Trials in Pittsburgh

Showing 16001-16020 of 18,076 trials

Safety Study of a Single Dose of REGN88(SAR153191)in Patients With Rheumatoid Arthritis

NCT01055899

This study will test the safety and tolerability (how the body reacts to the drug) of REGN88 and placebo (an inactive substance that contains no medicine) in patients with Rheumatoid Arthritis.

Rheumatoid Arthritis

Regeneron Pharmaceuticals15 participantsStarted Jul 2008

Duncansville, Pennsylvania, United States • Dallas, Texas, United States

COMPLETEDPhase 283 miles

Treatment Interruption of Natalizumab

NCT01071083

This is a randomized, rater blinded trial in patients who interrupt treatment with natalizumab with or without being treated with other immunomodulatory drugs, or continue treatment with natalizumab. The main purpose of this study is to find out the following, when participants stop taking natalizumab for 24 weeks: * when MS symptoms return, and * if other drugs for MS may help control MS symptoms during the natalizumab-interruption period. This study will also explore how quickly the effects of natalizumab return after resuming natalizumab dosing.

Relapsing Remitting Multiple Sclerosis

Biogen175 participantsStarted Mar 2010

Cullman, Alabama, United States • San Francisco, California, United States • Fort Collins, Colorado, United States +30 more locations

Safety Study of a Single Dose of REGN88(SAR153191)in Patients With Rheumatoid Arthritis

Treatment Interruption of Natalizumab

Find Trials by Condition in Pittsburgh

GW786034 in Treating Patients With Advanced Solid Tumors

Efficacy and Safety Study of Norethindrone Acetate Transdermal Delivery System in Contraception

Evaluation of the Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis

OVATIO CRT and SITUS OTW LV Lead Post Approval Study

Nutrition Intervention in Treating Women With Breast Cancer

Evaluation of Therapeutic Plasma Exchange (TPE) Procedure Using the AMICUS Device

A Study of Psychosocial and Behavioral Determinants of Differential Rates of Participant Compliance in CPCRA Protocols

Long-Term Safety and Efficacy Study of Milnacipran in Pediatric Patients With Primary Fibromyalgia

Conditioning, the Placebo Effect, and Psoriasis

Exploratory Study to Access the Metabolic Effects of Ranolazine in Subjects With Type 2 Diabetes Mellitus When Added to Ongoing Non-insulin Antidiabetic Therapy

A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Kidney Transplant Patients

A Dose Evaluation Study of the Effect of Plug Placement on the Efficacy and Safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma

A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors

A Phase I Study of BIIB015 in Relapsed/Refractory Solid Tumors

Effectiveness of a Training Program in Improving Coping Skills in People With Arthritis Pain

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma

TMC125-TiDP2-C238: An Exploratory Pharmacokinetics, Safety and Anti-HIV Activity Study of Etravirine (ETR) When Given With Boosted Atazanavir (ATV/Rtv) at Two Different Doses and 1 Nucleoside Reverse Transcriptase Inhibitor (NRTI) in Treatment Experienced HIV Patients

Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Measure Response to Etanercept in Rheumatoid Arthritis